AU2016905362A0 - Compounds and use thereof in methods of treatment - Google Patents
Compounds and use thereof in methods of treatmentInfo
- Publication number
- AU2016905362A0 AU2016905362A0 AU2016905362A AU2016905362A AU2016905362A0 AU 2016905362 A0 AU2016905362 A0 AU 2016905362A0 AU 2016905362 A AU2016905362 A AU 2016905362A AU 2016905362 A AU2016905362 A AU 2016905362A AU 2016905362 A0 AU2016905362 A0 AU 2016905362A0
- Authority
- AU
- Australia
- Prior art keywords
- compounds
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2017383102A AU2017383102B2 (en) | 2016-12-23 | 2017-12-21 | Inhibitors of SOX18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases |
PCT/AU2017/051439 WO2018112545A1 (en) | 2016-12-23 | 2017-12-21 | Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases |
CA3048040A CA3048040A1 (en) | 2016-12-23 | 2017-12-21 | Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases |
EP17884538.4A EP3558293A4 (en) | 2016-12-23 | 2017-12-21 | Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases |
CN201780086511.1A CN110536685A (en) | 2016-12-23 | 2017-12-21 | The inhibitor of SOX18 protein active is for treating angiogenesis-associated diseases and/or lymphatic vessel generation related disease |
KR1020197021576A KR102572077B1 (en) | 2016-12-23 | 2017-12-21 | Inhibitors of SOX18 protein activity for the treatment of angiogenesis- and/or lymphangiogenesis-related disorders |
JP2019534124A JP2020506884A (en) | 2016-12-23 | 2017-12-21 | Inhibitors of SOX18 protein activity for treatment of diseases associated with angiogenesis and / or lymphangiogenesis |
US16/472,882 US11434190B2 (en) | 2016-12-23 | 2017-12-21 | Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases |
US17/741,065 US20230100768A1 (en) | 2016-12-23 | 2022-05-10 | Inhibitors of sox18 protein activity for treating angiogenesis and/or lymphangiogenesis-related diseases |
JP2022162614A JP2023011613A (en) | 2016-12-23 | 2022-10-07 | Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases |
US18/342,312 US20240002326A1 (en) | 2016-12-23 | 2023-06-27 | Compounds and use thereof in methods of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2016905362A0 true AU2016905362A0 (en) | 2017-01-12 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3429635A4 (en) | Anti-crispr compounds and methods of use | |
EP3504213A4 (en) | Amino-pyrrolopyrimidinone compounds and methods of use thereof | |
EP3454945A4 (en) | Ash1l inhibitors and methods of treatment therewith | |
EP3328419A4 (en) | Pd-1-binding molecules and methods of use thereof | |
EP3377042A4 (en) | Materials and methods for treatment of titin-based myopathies and other titinopaties | |
EP3303634A4 (en) | Cas9 variants and methods of use thereof | |
EP3302562A4 (en) | Lag-3-binding molecules and methods of use thereof | |
EP3548033A4 (en) | Compounds and their methods of use | |
EP3325473A4 (en) | Compounds and uses thereof in the treatment of cancers and other medical conditions | |
EP3371306B8 (en) | Materials and methods for treatment of hemoglobinopathies | |
EP3487379A4 (en) | Medical devices and methods of use | |
EP3253387A4 (en) | Compounds and uses in treatment of senescence-associated conditons | |
EP3377070A4 (en) | Compounds and methods of their use | |
EP3554401A4 (en) | Ocular treatment devices and related methods of use | |
EP3373969A4 (en) | Glycan-interacting compounds and methods of use | |
EP3576738A4 (en) | Use of gaboxadol in the treatment of tinnitus | |
EP3526205A4 (en) | Therapeutic compounds and methods of use thereof | |
EP3133919A4 (en) | Agents and methods for treatment of pathogens | |
EP3706736A4 (en) | Ash1l degraders and methods of treatment therewith | |
EP3525703A4 (en) | Treatment devices and methods | |
EP3541847A4 (en) | Glycan-interacting compounds and methods of use | |
EP3496804A4 (en) | Bioelectric devices and methods of use | |
EP3236992A4 (en) | Peptides and their use in the treatment of skin | |
EP3134108A4 (en) | Agents and methods of treatment | |
EP3145573A4 (en) | Portable medical treatment system and method of use |